主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | 张颂义 | 否 | 762.63万 | 12.00% | 新增 | 新增 | -- |
| 2 | Johnson Lau | 否 | 670.76万 | 10.56% | 新增 | 新增 | -- |
| 3 | Ma Huateng | 否 | 652.40万 | 10.30% | 新增 | 新增 | -- |
| 4 | Prestine Victory Limited | 是 | 318.18万 | 5.00% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2023-05-05 | LAU JOHNSON YIU NAM |
|
25.04 | 1.36 | 是 | CEO and Chairman of the Board |
| 2023-05-05 | Kwan Rudolf |
|
4.98 | 1.36 | 是 | EVP, Chief Medical Officer |
| 2023-05-05 | Cook Timothy DeVere |
|
0.41 | 1.36 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-04-21 | Kwan Rudolf |
|
4.62 | 1.31 | 是 | EVP, Chief Medical Officer |
| 2023-04-21 | WU JINN |
|
3.48 | 1.31 | 是 | -- |
| 2023-04-21 | VIERLING JOHN |
|
1.23 | 1.31 | 是 | -- |
| 2023-04-21 | TSANG Benson Kwan Hung |
|
1.69 | 1.31 | 是 | -- |
| 2023-04-21 | Spiegel Robert J. |
|
0.46 | 1.31 | 是 | -- |
| 2023-04-21 | LAU JOHNSON YIU NAM |
|
24.20 | 1.31 | 是 | CEO and Chairman of the Board |
| 2023-04-21 | Fok Manson |
|
11.07 | 1.31 | 是 | -- |
| 2023-04-21 | Davis Stephanie A |
|
0.80 | 1.31 | 是 | -- |
| 2023-04-21 | Cook Timothy DeVere |
|
0.38 | 1.31 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-04-07 | Cook Timothy DeVere |
|
0.34 | 1.22 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-04-07 | Kwan Rudolf |
|
4.25 | 1.22 | 是 | EVP, Chief Medical Officer |
| 2023-04-07 | LAU JOHNSON YIU NAM |
|
23.33 | 1.22 | 是 | CEO and Chairman of the Board |
| 2023-03-24 | Kwan Rudolf |
|
3.84 | 1.39 | 是 | EVP, Chief Medical Officer |
| 2023-03-24 | Cook Timothy DeVere |
|
0.30 | 1.39 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-03-24 | LAU JOHNSON YIU NAM |
|
22.39 | 1.39 | 是 | CEO and Chairman of the Board |
| 2023-03-10 | Cook Timothy DeVere |
|
0.26 | 1.94 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-03-10 | Kwan Rudolf |
|
3.49 | 1.94 | 是 | EVP, Chief Medical Officer |
| 2023-03-10 | LAU JOHNSON YIU NAM |
|
21.57 | 1.94 | 是 | CEO and Chairman of the Board |
| 2023-02-24 | Kwan Rudolf |
|
3.24 | 2.74 | 是 | EVP, Chief Medical Officer |
| 2023-02-24 | LAU JOHNSON YIU NAM |
|
21.02 | 2.74 | 是 | CEO and Chairman of the Board |
| 2023-02-24 | Cook Timothy DeVere |
|
0.24 | 2.74 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-02-22 | Annoni Joe |
|
0.06 | -- | 是 | Chief Financial Officer |
| 2023-02-22 | Annoni Joe |
|
0.04 | 2.66 | 是 | Chief Financial Officer |
| 2023-02-10 | Cook Timothy DeVere |
|
4.36 | 0.23 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-02-10 | Kwan Rudolf |
|
61.20 | 0.23 | 是 | EVP, Chief Medical Officer |
| 2023-02-10 | LAU JOHNSON YIU NAM |
|
417.25 | 0.23 | 是 | CEO and Chairman of the Board |
| 2023-01-27 | LAU JOHNSON YIU NAM |
|
415.31 | 0.19 | 是 | CEO and Chairman of the Board |
| 2023-01-27 | Kwan Rudolf |
|
59.02 | 0.19 | 是 | EVP, Chief Medical Officer |
| 2023-01-27 | Cook Timothy DeVere |
|
4.14 | 0.19 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-01-13 | LAU JOHNSON YIU NAM |
|
413.06 | 0.19 | 是 | CEO and Chairman of the Board |
| 2023-01-13 | Davis Stephanie A |
|
8.75 | 0.19 | 是 | -- |
| 2023-01-13 | Cook Timothy DeVere |
|
3.88 | 0.19 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |
| 2023-01-13 | TSANG Benson Kwan Hung |
|
16.21 | 0.19 | 是 | -- |
| 2023-01-13 | WU JINN |
|
56.58 | 0.19 | 是 | -- |
| 2023-01-13 | Spiegel Robert J. |
|
4.58 | 0.19 | 是 | -- |
| 2023-01-13 | Kwan Rudolf |
|
56.49 | 0.19 | 是 | EVP, Chief Medical Officer |
| 2023-01-13 | VIERLING JOHN |
|
11.63 | 0.19 | 是 | -- |
| 2023-01-13 | Fok Manson |
|
209.86 | 0.19 | 是 | -- |
| 2022-12-30 | LAU JOHNSON YIU NAM |
|
410.71 | 0.15 | 是 | CEO and Chairman of the Board |
| 2022-12-30 | Kwan Rudolf |
|
53.86 | 0.15 | 是 | EVP, Chief Medical Officer |
| 2022-12-30 | Cook Timothy DeVere |
|
3.61 | 0.15 | 是 | Chief Business and Commercial Officer, Proprietary Drugs |